Global Drug Safety and Pharmacovigilance Software Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Drug Safety and Pharmacovigilance Software market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
AB cube
Sparta Systems, Inc.
ArisGlobal
Max Application
Oracle Corporation
Ennov Solutions Inc
Sarjen Systems
Online Business Applications Inc
EXTEDO GmbH
United BioSource Corporation
By Types:
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software
By Applications:
Pharma & Biotech Companies
CROs
BPOs
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Drug Safety and Pharmacovigilance Software Revenue
1.5 Market Analysis by Type
1.5.1 Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 ADR Reporting
1.5.3 Drug Safety Audits
1.5.4 Issue Tracking
1.5.5 Fully Integrated Software
1.6 Market by Application
1.6.1 Global Drug Safety and Pharmacovigilance Software Market Share by Application: 2022-2027
1.6.2 Pharma & Biotech Companies
1.6.3 CROs
1.6.4 BPOs
1.6.5 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Drug Safety and Pharmacovigilance Software Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Drug Safety and Pharmacovigilance Software Market Players Profiles
3.1 AB cube
3.1.1 AB cube Company Profile
3.1.2 AB cube Drug Safety and Pharmacovigilance Software Product Specification
3.1.3 AB cube Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Sparta Systems, Inc.
3.2.1 Sparta Systems, Inc. Company Profile
3.2.2 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Product Specification
3.2.3 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 ArisGlobal
3.3.1 ArisGlobal Company Profile
3.3.2 ArisGlobal Drug Safety and Pharmacovigilance Software Product Specification
3.3.3 ArisGlobal Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Max Application
3.4.1 Max Application Company Profile
3.4.2 Max Application Drug Safety and Pharmacovigilance Software Product Specification
3.4.3 Max Application Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Oracle Corporation
3.5.1 Oracle Corporation Company Profile
3.5.2 Oracle Corporation Drug Safety and Pharmacovigilance Software Product Specification
3.5.3 Oracle Corporation Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 Ennov Solutions Inc
3.6.1 Ennov Solutions Inc Company Profile
3.6.2 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Product Specification
3.6.3 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Sarjen Systems
3.7.1 Sarjen Systems Company Profile
3.7.2 Sarjen Systems Drug Safety and Pharmacovigilance Software Product Specification
3.7.3 Sarjen Systems Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Online Business Applications Inc
3.8.1 Online Business Applications Inc Company Profile
3.8.2 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Product Specification
3.8.3 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 EXTEDO GmbH
3.9.1 EXTEDO GmbH Company Profile
3.9.2 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Product Specification
3.9.3 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 United BioSource Corporation
3.10.1 United BioSource Corporation Company Profile
3.10.2 United BioSource Corporation Drug Safety and Pharmacovigilance Software Product Specification
3.10.3 United BioSource Corporation Drug Safety and Pharmacovigilance Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Drug Safety and Pharmacovigilance Software Market Competition by Market Players
4.1 Global Drug Safety and Pharmacovigilance Software Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Market Players (2016-2021)
4.3 Global Drug Safety and Pharmacovigilance Software Average Price by Market Players (2016-2021)
5 Global Drug Safety and Pharmacovigilance Software Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.1.2 Drug Safety and Pharmacovigilance Software Key Players in North America (2016-2021)
5.1.3 North America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.1.4 North America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.2.2 Drug Safety and Pharmacovigilance Software Key Players in East Asia (2016-2021)
5.2.3 East Asia Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.2.4 East Asia Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.3.2 Drug Safety and Pharmacovigilance Software Key Players in Europe (2016-2021)
5.3.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.3.4 Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.4.2 Drug Safety and Pharmacovigilance Software Key Players in South Asia (2016-2021)
5.4.3 South Asia Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.4.4 South Asia Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.5.2 Drug Safety and Pharmacovigilance Software Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.5.4 Southeast Asia Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.6.2 Drug Safety and Pharmacovigilance Software Key Players in Middle East (2016-2021)
5.6.3 Middle East Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.6.4 Middle East Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.7.2 Drug Safety and Pharmacovigilance Software Key Players in Africa (2016-2021)
5.7.3 Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.7.4 Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.8.2 Drug Safety and Pharmacovigilance Software Key Players in Oceania (2016-2021)
5.8.3 Oceania Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.8.4 Oceania Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.9.2 Drug Safety and Pharmacovigilance Software Key Players in South America (2016-2021)
5.9.3 South America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.9.4 South America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Drug Safety and Pharmacovigilance Software Market Size (2016-2021)
5.10.2 Drug Safety and Pharmacovigilance Software Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021)
5.10.4 Rest of the World Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021)
6 Global Drug Safety and Pharmacovigilance Software Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Drug Safety and Pharmacovigilance Software Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Drug Safety and Pharmacovigilance Software Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Drug Safety and Pharmacovigilance Software Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Drug Safety and Pharmacovigilance Software Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Drug Safety and Pharmacovigilance Software Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Drug Safety and Pharmacovigilance Software Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Drug Safety and Pharmacovigilance Software Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Drug Safety and Pharmacovigilance Software Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Drug Safety and Pharmacovigilance Software Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Drug Safety and Pharmacovigilance Software Consumption by Countries
7 Global Drug Safety and Pharmacovigilance Software Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Drug Safety and Pharmacovigilance Software (2022-2027)
7.2 Global Forecasted Revenue of Drug Safety and Pharmacovigilance Software (2022-2027)
7.3 Global Forecasted Price of Drug Safety and Pharmacovigilance Software (2022-2027)
7.4 Global Forecasted Production of Drug Safety and Pharmacovigilance Software by Region (2022-2027)
7.4.1 North America Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.3 Europe Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.7 Africa Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.9 South America Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Drug Safety and Pharmacovigilance Software Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Application (2022-2027)
8 Global Drug Safety and Pharmacovigilance Software Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.2 East Asia Market Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.3 Europe Market Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Countriy
8.4 South Asia Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.5 Southeast Asia Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.6 Middle East Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.7 Africa Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.8 Oceania Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.9 South America Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
8.10 Rest of the world Forecasted Consumption of Drug Safety and Pharmacovigilance Software by Country
9 Global Drug Safety and Pharmacovigilance Software Sales by Type (2016-2027)
9.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Type (2016-2021)
9.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Type (2022-2027)
10 Global Drug Safety and Pharmacovigilance Software Consumption by Application (2016-2027)
10.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Application (2016-2021)
10.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Application (2022-2027)
11 Global Drug Safety and Pharmacovigilance Software Manufacturing Cost Analysis
11.1 Drug Safety and Pharmacovigilance Software Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Drug Safety and Pharmacovigilance Software
12 Global Drug Safety and Pharmacovigilance Software Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Drug Safety and Pharmacovigilance Software Distributors List
12.3 Drug Safety and Pharmacovigilance Software Customers
12.4 Drug Safety and Pharmacovigilance Software Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
Research Methodology:
Drug Safety and Pharmacovigilance Software Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|